Why is Acutaas Chemicals Ltd falling/rising?

Jan 06 2026 02:27 AM IST
share
Share Via
On 05-Jan, Acutaas Chemicals Ltd's stock price rose by 1.14% to ₹1,770, continuing a six-day winning streak driven by robust financial performance and sustained market outperformance.




Consistent Gains Reflect Positive Momentum


Acutaas Chemicals has been on a notable upward trajectory, with the stock gaining for six consecutive days and delivering a 7.17% return during this period. The stock outperformed its sector by 0.65% on the day, reaching an intraday high of ₹1,792, a 2.4% increase from the previous close. This momentum is further underscored by the stock trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day marks, signalling strong technical support and investor confidence.


Market-Beating Returns Over Multiple Timeframes


Over the past year, Acutaas Chemicals has delivered an impressive 67.77% return, significantly outpacing the Sensex’s 7.85% gain. The stock’s three-year performance is even more striking, with a 273.22% increase compared to the Sensex’s 41.57%. This long-term outperformance highlights the company’s ability to generate substantial shareholder value and maintain growth momentum in a competitive market environment.



Our latest weekly pick is live! This Large Cap from Diamond & Gold Jewellery comes with clear entry and exit targets. See the detailed report with target price now!



  • - Clear entry/exit targets

  • - Target price revealed

  • - Detailed report available



View Target Price Report →



Strong Fundamentals Underpin Share Price Strength


The company’s robust financial health is a key driver behind the stock’s rise. Acutaas Chemicals boasts a zero debt-to-equity ratio on average, indicating a clean balance sheet and low financial risk. Its net sales have grown at an annual rate of 27.10%, while operating profit has expanded by 32.44%, reflecting efficient operations and strong demand for its products.


Recent results have been particularly encouraging, with net profit growth of 63.28% reported in September 2025. The company has consistently declared positive results for five consecutive quarters, signalling sustained operational excellence. Net sales for the latest six months stood at ₹513.44 crores, growing 21.27% year-on-year. Additionally, the company’s return on capital employed (ROCE) reached a high of 21.30%, and its inventory turnover ratio was an impressive 5.74 times, both indicators of effective capital utilisation and inventory management.


Institutional Confidence and Liquidity Support


Institutional investors hold a significant 39.44% stake in Acutaas Chemicals, reflecting confidence from well-informed market participants with the resources to analyse the company’s fundamentals thoroughly. This backing often provides stability and can attract further investment interest. The stock’s liquidity is adequate for sizeable trades, with a trading capacity of approximately ₹1.1 crore based on 2% of the five-day average traded value, ensuring smooth execution for investors.


Risks and Valuation Considerations


Despite the positive outlook, investors should be mindful of valuation metrics. The company’s return on equity (ROE) stands at 15.8%, and it trades at a price-to-book value of 10.3, which is considered expensive. However, this valuation is in line with historical averages for its peer group. The price-to-earnings-to-growth (PEG) ratio of 0.5 suggests that the stock’s price growth is supported by strong profit expansion, which increased by 139.8% over the past year, mitigating some concerns about the premium valuation.



Want to dive deeper on Acutaas Chemical? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!



  • - Real-time research report

  • - Complete fundamental analysis

  • - Peer comparison included



Read the Full Verdict →



Conclusion: Why Acutaas Chemicals Is Rising


The rise in Acutaas Chemicals Ltd’s share price on 05-Jan is primarily driven by its strong financial performance, consistent positive quarterly results, and market-beating returns over multiple time horizons. The company’s zero debt position, healthy sales and profit growth, and efficient capital management underpin investor confidence. Institutional backing and favourable technical indicators further support the stock’s upward momentum. While valuation remains on the higher side, the robust profit growth and reasonable PEG ratio provide justification for the premium. Overall, the stock’s rise reflects a combination of solid fundamentals and sustained market optimism.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News